An article titled “21 International Experts Dispute Prevailing US Gender Transition Methods” published by The Epoch Times on July 15, 2023, discusses the concerns raised by 21 clinicians and researchers from nine countries regarding the current treatment methods for gender dysphoria in the United States. These experts argue that the best available evidence does not support the use of sex-change procedures, particularly for minors. They criticize the Endocrine Society’s endorsement of hormone treatments that block puberty in minors, stating that the evidence for mental health benefits from such interventions is of low or very low certainty.
The experts’ concerns were prompted by the Endocrine Society’s criticism of an op-ed that questioned a federal court ruling which struck down an Arkansas law banning sex-change procedures for minors. The court ruling relied on the Endocrine Society’s guidelines, which are based on low-quality evidence and influenced by transgender activists.
In response to these criticisms, the Endocrine Society’s president, Dr. Stephen Hammes, defended the guidelines, stating they were developed through a rigorous process and based on extensive evidence. He argued that more than 2000 studies since 1975 show that gender-affirming care improves the well-being of transgender and gender-diverse people and reduces the risk of suicide.
However, the group of international experts disputes this claim, stating that the best available evidence does not support the assertion that sex-change procedures improve well-being. They argue that the risks of such procedures, which include sterility, lifelong dependence on medication, and regret, are significant, while the benefits are very low.
They also contradict the claim that gender transition reduces suicides, stating that there is no reliable evidence to support this, and call for medical societies to align their recommendations with the best available evidence, cautioning against exaggerating benefits and minimizing risks.